NYSE American - Nasdaq Real Time Price USD

OS Therapies Incorporated (OSTX)

1.9400
-0.0300
(-1.52%)
As of 1:29:48 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
6,813.8460
6,813.8460
4,342.6470
4,446.2990
4,837.3550
Operating Income
-6,813.8460
-6,813.8460
-4,342.6470
-4,446.2990
-4,837.3550
Net Non Operating Interest Income Expense
-2,051.8390
-2,051.8390
-3,448.9370
-1,808.3860
-2,582.8930
Other Income Expense
-17.2530
-17.2530
--
--
--
Pretax Income
-8,882.9380
-8,882.9380
-7,791.5840
-6,254.6850
-7,420.2480
Net Income Common Stockholders
-10,886.1630
-10,886.1630
-7,916.5840
-6,379.6850
-7,513.9980
Diluted NI Available to Com Stockholders
-10,886.1630
-10,886.1630
-7,916.5840
-6,379.6850
-7,513.9980
Basic EPS
-0.88
--
-0.38
-0.32
-0.33
Diluted EPS
-0.88
--
-0.38
-0.32
-0.33
Basic Average Shares
12,377.2990
--
20,597.7770
23,100.8190
23,100.8190
Diluted Average Shares
12,377.2990
--
20,597.7770
23,100.8190
23,100.8190
Total Operating Income as Reported
-6,813.8460
-6,813.8460
-4,342.6470
-4,446.2990
-4,837.3550
Total Expenses
6,813.8460
6,813.8460
4,342.6470
4,446.2990
4,837.3550
Net Income from Continuing & Discontinued Operation
-8,882.9380
-8,882.9380
-7,791.5840
-6,254.6850
-7,420.2480
Normalized Income
-8,882.9380
-8,882.9380
-7,791.5840
-6,254.6850
-7,420.2480
Interest Income
0
0
0.0020
0
--
Interest Expense
2,051.8390
2,051.8390
3,448.9390
1,808.3860
2,582.8930
Net Interest Income
-2,051.8390
-2,051.8390
-3,448.9370
-1,808.3860
-2,582.8930
EBIT
-6,831.0990
-6,831.0990
-4,342.6450
-4,446.2990
-4,837.3550
EBITDA
-6,828.3190
-6,828.3190
-4,338.4250
-4,445.4940
-4,836.5500
Reconciled Depreciation
2.7800
2.7800
4.2200
0.8050
0.8050
Net Income from Continuing Operation Net Minority Interest
-8,882.9380
-8,882.9380
-7,791.5840
-6,254.6850
-7,420.2480
Normalized EBITDA
-6,828.3190
-6,828.3190
-4,338.4250
-4,445.4940
-4,836.5500
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 8/1/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ZVSA ZyVersa Therapeutics, Inc.
0.5247
-8.14%
 
THAR Tharimmune, Inc.
1.5150
+1.68%
 
TOVX Theriva Biologics, Inc.
0.5150
-19.93%
 
PRTG Portage Biotech Inc.
8.65
-4.10%
 
GRI GRI Bio, Inc.
1.5200
-5.00%
 
PHIO Phio Pharmaceuticals Corp.
1.7650
-1.94%
 
PTIX Protagenic Therapeutics, Inc.
3.3499
-4.35%
 
IBO Impact BioMedical Inc.
0.5516
+10.71%
 
CAMP CAMP4 THERAPEUTICS CORPORATION
2.0900
-2.34%
 
VSTM Verastem, Inc.
7.21
+3.82%